| Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range |
147 |
| Group-based multi-trajectory modeling |
58 |
| Compositional data analysis for physical activity, sedentary time and sleep research |
49 |
| Sample size for binary logistic prediction models: Beyond events per variable criteria |
43 |
| The compositional isotemporal substitution model: A method for estimating changes in a health outcome for reallocation of time between sleep, physical activity and sedentary behaviour |
33 |
| Should multiple imputation be the method of choice for handling missing data in randomized trials? |
26 |
| The choice of methods in determining the optimal cut-off value for quantitative diagnostic test evaluation |
22 |
| Propensity score analysis with partially observed covariates: How should multiple imputation be used? |
22 |
| Modeling the spread of Middle East respiratory syndrome coronavirus in Saudi Arabia |
21 |
| Multiple imputation by chained equations for systematically and sporadically missing multilevel data |
19 |
| Impact of non-uniform correlation structure on sample size and power in multiple-period cluster randomised trials |
18 |
| One-stage dose-response meta-analysis for aggregated data |
16 |
| Including historical data in the analysis of clinical trials: Is it worth the effort? |
13 |
| Propensity score matching and complex surveys |
13 |
| Use of the concordance index for predictors of censored survival data |
13 |
| Confidence and coverage for Bland-Altman limits of agreement and their approximate confidence intervals |
12 |
| ANOVA model for network meta-analysis of diagnostic test accuracy data |
11 |
| An overview of methods for network meta-analysis using individual participant data: when do benefits arise? |
11 |
| Efficient body fat estimation using multistage pair ranked set sampling |
10 |
| Recommendations on multiple testing adjustment in multi-arm trials with a shared control group |
10 |
| Now trending: Coping with non-parallel trends in difference-in-differences analysis |
10 |
| Controlled multi-arm platform design using predictive probability |
10 |
| Exact confidence limits for the response rate in two-stage designs with over- or under-enrollment in the second stage |
9 |
| Identification of predicted individual treatment effects in randomized clinical trials |
9 |
| Optimized adaptive enrichment designs |
9 |
| Inference for the treatment effect in multiple-period cluster randomised trials when random effect correlation structure is misspecified |
9 |
| Prediction intervals for random-effects meta-analysis: A confidence distribution approach |
8 |
| Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator |
8 |
| A simple method to estimate the time-dependent receiver operating characteristic curve and the area under the curve with right censored data |
8 |
| A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes |
8 |
| Individual treatment effect prediction for amyotrophic lateral sclerosis patients |
8 |
| An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring |
8 |
| Extending multivariate-t linear mixed models for multiple longitudinal data with censored responses and heavy tails |
8 |
| A review of statistical updating methods for clinical prediction models |
8 |
| Robust functional regression model for marginal mean and subject-specific inferences |
7 |
| Leveraging electronic health records for predictive modeling of post-surgical complications |
7 |
| Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees |
7 |
| A review and comparison of Bayesian and likelihood-based inferences in beta regression and zero-or-one-inflated beta regression |
7 |
| Dynamic predictions in Bayesian functional joint models for longitudinal and time-to-event data: An application to Alzheimer's disease |
7 |
| Meta-analysis of prediction model performance across multiple studies: Which scale helps ensure between-study normality for the C-statistic and calibration measures? |
7 |
| Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods |
7 |
| Continuously updated network meta-analysis and statistical monitoring for timely decision-making |
7 |
| Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: Meta-analysis with a joint model |
7 |
| Model-based sensitivity analysis for outcome reporting bias in the meta analysis of benefit and harm outcomes |
6 |
| Scalable collaborative targeted learning for high-dimensional data |
6 |
| Mixed hidden Markov quantile regression models for longitudinal data with possibly incomplete sequences |
6 |
| On adaptive propensity score truncation in causal inference |
6 |
| A new parsimonious model for ordinal longitudinal data with application to subjective evaluations of a gastrointestinal disease |
6 |
| Estimating under-five mortality in space and time in a developing world context |
6 |
| Joint longitudinal and time-to-event models for multilevel hierarchical data |
6 |
